Reuter's Health: Boosting sonic hedgehog signaling
UC neuroscientist and Parkinson’s expert weighs in on new study
Alberto Espay, director and endowed chair, Gardner Family Center for Parkinson's disease and Movement Disorders at the University of Cincinnati, gave Reuter's Health his opinion on a new study of Parkinson’s disease.
The study, an animal model, looks at whether increasing sonic hedgehog protein signaling decreases the involuntary movements associated with L-dopa-induced dyskinesia (LID). LID is a side effect of dopamine replacement therapy, leading to involuntary movements in the limbs, face and torso of Parkinson's patients. The research comes out of the CUNY School of Medicine and the Graduate Center in New York City.
Espay called the study "intriguing preclinical work" that could open "a novel avenue of investigation into LID."
Featured image at top: Alberto Espay/UC Creative + Brand
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.
What is squalane, and how does it work to moisturize skin?
October 27, 2025
The University of Cincinnati's Kelly Dobos was featured in a Women's Health article discussing squalane, an ingredient being increasingly used in moisturizing skincare products.